Skip to main content
Have a personal or library account? Click to login
Moderate continuous versus high-intensity interval training on gut dysbiosis and glucagon-like peptide hormone in irritable bowel syndrome Cover

Moderate continuous versus high-intensity interval training on gut dysbiosis and glucagon-like peptide hormone in irritable bowel syndrome

Open Access
|Mar 2026

References

  1. Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. doi: 10.1038/s41392-022-00974-4.
  2. Colella M, Charitos IA, Ballini A, Cafiero C, Topi S, Palmirotta R, et al. Microbiota revolution: how gut microbes regulate our lives. World J Gastroenterol. 2023;29(28):4368–83. doi: 10.3748/wjg.v29.i28.4368.
  3. Kim S, Seo SU, Kweon MN. Gut microbiota-derived metabolites tune host homeostasis fate. Semin Immunopathol. 2024;46(1):2. doi: 10.1007/s00281-024-01012-x.
  4. Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21(1):212. doi: 10.1186/s12964-023-01219-9.
  5. O'Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572. doi: 10.1016/j.mce.2022.111572.
  6. Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut Microbiota and short chain fatty acids: implications in glucose homeostasis. Int J Mol Sci. 2022;23(3). doi: 10.3390/ijms23031105.
  7. Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3). doi: 10.3390/microorganisms10030578.
  8. Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R, et al. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. J Acad Nutr Diet. 2020;120(4):565–86. doi: 10.1016/j.jand.2019.05.015.
  9. Boulos M, Mousa RS, Jeries N, Simaan E, Alam K, Bulus B, et al. Hidden in the fat: unpacking the metabolic tango between metabolic dysfunction-associated steatotic liver disease and metabolic syndrome. Int J Mol Sci. 2025;26(7):3448. doi: 10.3390/ijms26073448.
  10. Acevedo-Román A, Pagán-Zayas N, Velázquez-Rivera LI, Torres-Ventura AC, Godoy-Vitorino F. Insights into gut dysbiosis: inflammatory diseases, obesity, and restoration approaches. Int J Mol Sci. 2024;25(17):9715. doi: 10.3390/ijms25179715.
  11. Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S, et al. Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms. 2023;11(10). doi: 10.3390/microorganisms11102369.
  12. Varghese S, Rao S, Khattak A, Zamir F, Chaari A. Physical exercise and the gut microbiome: a bidirectional relationship influencing health and performance. Nutrients. 2024;16(21). doi: 10.3390/nu16213663.
  13. Cataldi S, Bonavolontà V, Poli L, Clemente FM, De Candia M, Carvutto R, et al. The relationship between physical activity, physical exercise, and human gut microbiota in healthy and unhealthy subjects: a systematic review. Biology. 2022;11(3). doi: 10.3390/biology11030479.
  14. Aragón-Vela J, Solis-Urra P, Ruiz-Ojeda FJ, Álvarez-Mercado AI, Olivares-Arancibia J, Plaza-Diaz J. Impact of exercise on gut microbiota in obesity. Nutrients. 2021;13(11). doi: 10.3390/nu13113999.
  15. Bubnov R, Spivak M. Pathophysiology based individualized use of probiotics and prebiotics for metabolic syndrome: implementing predictive, preventive, and personalized medical approach. Advances in predictive, preventive and personalised medicine—microbiome in 3P medicine strategies. Cham: Springer International Publishing; 2023. p. 133–96.
  16. Gao C, Wei J, Lu C, Wang L, Dong D, Sun M. A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases. Gut Microbes. 2024;16(1):2404141. doi: 10.1080/19490976.2024.2404141.
  17. Ribichini E, Scalese G, Cesarini A, Mocci C, Pallotta N, Severi C, et al. Exercise-induced gastrointestinal symptoms in endurance sports: a review of pathophysiology, symptoms, and nutritional management. Dietetics. 2023;2(3):289–307. doi: 10.3390/dietetics2030021.
  18. Al-Beltagi M, Saeed NK, Bediwy AS, El-Sawaf Y, Elbatarny A, Elbeltagi R. Exploring the gut-exercise link: a systematic review of gastrointestinal disorders in physical activity. World J Gastroenterol. 2025;31(22):106835. doi: 10.3748/wjg.v31.i22.106835.
  19. Rojas-Valverde D, Bonilla DA, Gómez-Miranda LM, Calleja-Núñez JJ, Arias N, Martínez-Guardado I. Examining the interaction between exercise, gut microbiota, and neurodegeneration: future research directions. Biomedicines. 2023;11(8). doi: 10.3390/biomedicines11082267.
  20. Bycura D, Santos AC, Shiffer A, Kyman S, Winfree K, Sutliffe J, et al. Impact of different exercise modalities on the human gut microbiome. Sports (Basel). 2021;9(2). doi: 10.3390/sports9020014.
  21. Lavin KM, Coen PM, Baptista LC, Bell MB, Drummer D, Harper SA, et al. State of knowledge on molecular adaptations to exercise in humans: historical perspectives and future directions. Compr Physiol. 2022;12(2):3193–279. doi: 10.1002/cphy.c200033.
  22. Suryani D, Subhan Alfaqih M, Gunadi JW, Sylviana N, Goenawan H, Megantara I, et al. Type, intensity, and duration of exercise as regulator of gut microbiome profile. Curr Sports Med Rep. 2022;21(3):84–91. doi: 10.1249/jsr.0000000000000940.
  23. Han Y, Quan H, Ji W, Tian Q, Liu X, Liu W. Moderate-intensity continuous training and high-intensity interval training alleviate glycolipid metabolism through modulation of gut microbiota and their metabolite SCFAs in diabetic rats. Biochem Biophys Res Commun. 2024;735:150831. doi: 10.1016/j.bbrc.2024.150831.
  24. Hailu GN, Gebremariam MM, Meles HA. The role of exercise in alleviating irritable bowel syndrome (IBS) symptoms: addressing diagnostic challenges and management shortcomings. Egypt J Intern Med. 2025;37(1):32. doi: 10.1186/s43162-025-00424-x.
  25. Morariu ID, Avasilcai L, Vieriu M, Lupu VV, Morariu BA, Lupu A, et al. Effects of a low-FODMAP diet on irritable bowel syndrome in both children and adults - a narrative review. Nutrients. 2023;15(10). doi: 10.3390/nu15102295.
  26. Li C, Li J, Zhou Q, Wang C, Hu J, Liu C. Effects of physical exercise on the microbiota in irritable bowel syndrome. Nutrients. 2024;16(16). doi: 10.3390/nu16162657.
  27. Jayasinghe M, Karunanayake V, Mohtashim A, Caldera D, Mendis P, Prathiraja O, et al. The role of diet in the management of irritable bowel syndrome: a comprehensive review. Cureus. 2024;16(2):e54244. doi: 10.7759/cureus.54244.
  28. Yin Y, Guo Q, Zhou X, Duan Y, Yang Y, Gong S, et al. Role of brain-gut-muscle axis in human health and energy homeostasis. Front Nutr. 2022;9:947033. doi: 10.3389/fnut.2022.947033.
  29. Thomas-Dupont P, Velázquez-Soto H, Izaguirre-Hernández IY, Amieva-Balmori M, Triana-Romero A, Islas-Vázquez L, et al. Obesity contributes to inflammation in patients with IBS via complement component 3 and C-reactive protein. Nutrients. 2022;14(24). doi: 10.3390/nu14245227.
  30. Zeid W, Ezzeldeen E, Khattab M, Ahmed S, Abdo M. Effect of vitamin D3 (cholecalciferol) supplementation on gastrointestinal symptoms in patients with irritable bowel syndrome attending El-Mahsama family practice center, Ismailia, Egypt: a randomized clinical trial. Al-Azhar Intern Med J. 2020;1(7):37–42. doi: 10.21608/aimj.2020.32333.1254.
  31. Hou X, Chen S, Zhang Y, Sha W, Yu X, Elsawah H, et al. Quality of life in patients with irritable bowel syndrome (IBS), assessed using the IBS-quality of life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. Clin Drug Investig. 2014;34(11):783–93. doi: 10.1007/s40261-014-0233-y.
  32. Mytinger M, Nelson RK, Zuhl M. Exercise prescription guidelines for cardiovascular disease patients in the absence of a baseline stress test. J Cardiovasc Dev Dis. 2020;7(2):15. doi: 10.3390/jcdd7020015.
  33. Li Y, Zhao W, Yang Q. Effects of high-intensity interval training and moderate-intensity continuous training on mitochondrial dynamics in human skeletal muscle. Front Physiol. 2025;16:1554222. doi: 10.3389/fphys.2025.1554222.
  34. Mostafavi Abdolmaleky H, Zhou JR. Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases. Antioxidants. 2024;13(8):985. doi: 10.3390/antiox13080985.
  35. Bianco A, Russo F, Franco I, Riezzo G, Donghia R, Curci R, et al. Enhanced physical capacity and gastrointestinal symptom improvement in Southern Italian IBS patients following three months of moderate aerobic exercise. J Clin Med. 2023;12(21). doi: 10.3390/jcm12216786.
  36. Dalton A, Mermier C, Zuhl M. Exercise influence on the microbiome-gut-brain axis. Gut Microbes. 2019;10(5):555–68. doi: 10.1080/19490976.2018.1562268.
  37. Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, et al. The Effectiveness of synbiotic preparation containing lactobacillus and bifidobacterium probiotic strains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome - a randomized double-blind, placebo-controlled study. Nutrients. 2020;12(7). doi: 10.3390/nu12071999.
  38. Gevers D, Kugathasan S, Denson Lee A, Vázquez-Baeza Y, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15(3):382–92. doi: 10.1016/j.chom.2014.02.005.
  39. Motiani KK, Collado MC, Eskelinen JJ, Virtanen KA, Löyttyniemi E, Salminen S, et al. Exercise training modulates gut microbiota profile and improves endotoxemia. Med Sci Sports Exerc. 2020;52(1):94–104. doi: 10.1249/mss.0000000000002112.
  40. Fani M, Mostamand J, Fani M, Chitsaz N, Feizi A. The effect of aerobic exercises among women with mild and moderate irritable bowel syndrome: a pilot study. J Bodyw Mov Ther. 2019;23(1):161–5. doi: 10.1016/j.jbmt.2018.02.003.
  41. Groenendijk DW, Witteman BJ, Mulder BC. The experiences of female IBS patients concerning physical activity as treatment modality: a qualitative study. Qual Health Res. 2022;32(11):1690–700. doi: 10.1177/10497323221110109.
  42. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018;50(4):747–57. doi: 10.1249/mss.0000000000001495.
  43. Huang L, Li T, Zhou M, Deng M, Zhang L, Yi L, et al. Hypoxia improves endurance performance by enhancing short chain fatty acids production via gut microbiota remodeling. Front Microbiol. 2022;12:820691. doi: 10.3389/fmicb.2021.820691.
  44. Chen S, Shen C, Zeng X, Sun L, Luo F, Wan R, et al. Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases. Front Microbiol. 2025;16:1515364. doi: 10.3389/fmicb.2025.1515364.
  45. Nikolaki MD, Kasti AN, Katsas K, Petsis K, Lambrinou S, Patsalidou V, et al. The low-FODMAP diet, IBS, and BCFAs: exploring the positive, negative, and less desirable aspects - a literature review. Microorganisms. 2023;11(10). doi: 10.3390/microorganisms11102387.
  46. Farup PG, Rudi K, Hestad K. Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? BMC Gastroenterol. 2016;16(1):51. doi: 10.1186/s12876-016-0446-z.
  47. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73(4):1073–8. doi: 10.1128/aem.02340-06.
  48. Magzal F, Shochat T, Haimov I, Tamir S, Asraf K, Tuchner-Arieli M, et al. Increased physical activity improves gut microbiota composition and reduces short-chain fatty acid concentrations in older adults with insomnia. Sci Rep. 2022;12(1):2265. doi: 10.1038/s41598-022-05099-w.
  49. Dombrowski SU, Knittle K, Avenell A, Araújo-Soares V, Sniehotta FF. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ. 2014;348:g2646. doi: 10.1136/bmj.g2646.
  50. Sales KM, Reimer RA. Unlocking a novel determinant of athletic performance: The role of the gut microbiota, short-chain fatty acids, and “biotics” in exercise. J Sport Health Sci. 2023;12(1):36–44. doi: 10.1016/j.jshs.2022.09.002.
  51. Wewege M, van den Berg R, Ward RE, Keech A. The effects of high-intensity interval training vs. moderate-intensity continuous training on body composition in overweight and obese adults: a systematic review and meta-analysis. Obes Rev. 2017;18(6):635–46. doi: 10.1111/obr.12532.
  52. Hu M, Kong Z, Shi Q, Nie J. Acute effect of high-intensity interval training versus moderate-intensity continuous training on appetite-regulating gut hormones in healthy adults: a systematic review and meta-analysis. Heliyon. 2023;9(2):e13129. doi: 10.1016/j.heliyon.2023.e13129.
  53. Matos VA, Souza DC, Santos VO, Medeiros ÍF, Browne RA, Nascimento PR, et al. Acute effects of high-intensity interval and moderate-intensity continuous exercise on GLP-1, appetite and energy intake in obese men: A crossover trial. Nutrients. 2018;10(7):889. doi: 10.3390/nu10070889.
Language: English
Page range: 69 - 86
Submitted on: Jun 25, 2025
Accepted on: Nov 7, 2025
Published on: Mar 31, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Marwa Saeed Mohamed Mansour Salama et al., published by Józef Piłsudski University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.